Impaired glucose metabolism in colorectal cancer

References

• Maynard GD. Statistical study in cancer death rates. Biometrica 1910; 7: 276–304
   Google Scholar
• Doering CR. Statistical methods. Preventive medicine and hygiene6th ed, CR Rosenau. Appelton Century, New York 1935; 1221–60
   Google Scholar
• Wilson EB, Maher HC. Cancer and tuberculosis with some comments on cancer and other diseases. Am J Cancer 1932; 16: 227–50
   Google Scholar
• Weiderpass E, Gridley G, Nyren O, Berne C, Linet MS, Ekbom A, et al. Diabetes mellitus and risk of large bowel cancer. J Ntl Cancer Inst 1997; 89: 660–1
   PubMedGoogle Scholar
• Williams JC, Walsh DA, Jackson JF. Colon carcinoma and diabetes mellitus. Cancer 1984; 54: 3070–1
   PubMed Web of Science ®Google Scholar
• Muszyński J, Jóźwicka E, Szadkowski A. Zaburzenia tolerancji węglowodanów u chorych na raka jelita grubego. Pol Tyg Lek 1990; 45: 1005–7
   PubMedGoogle Scholar
• Joslin EP, Lombard LH, Burrows RE. Diabetes and cancer. N Engl J Med 1959; 262: 486–8
   Google Scholar
• Czyżyk, A. Patofizjologia i klinika cukrzycy. PWN Warszawa 1997.
   Google Scholar
• Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the US. Diabetes 2002; 51: 2170–8
   PubMed Web of Science ®Google Scholar
• Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91: 542–7
   PubMed Web of Science ®Google Scholar
• Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy K, Dechaud H, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92: 1592–600
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Negri E, Decarli A, Franceschi S. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1997; 6: 1007–10
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994; 70: 950–3
   PubMed Web of Science ®Google Scholar
• Le Marchand L, Wilkens LR, Kolonel LN. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes mellitus with the risk of colorectal cancer. Cancer Res 1997; 57: 4787–94
   PubMed Web of Science ®Google Scholar
• Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Post-load plasma glucose and cancer mortality in middle-aged men and women: 12-year follow-up findings of the Chicago Heart Association Detection Project in Industry. Am J Epidemiol 1990; 131: 254–62
   PubMedGoogle Scholar
• Will JC, Galuska DA, Vinicor F, Calle E. Colorectal cancer: another complication of diabetes mellitus?. Am J Epidemiol 1998; 147: 816–25
   PubMed Web of Science ®Google Scholar
• Young-In Kim. Diet, lifestyle and colorectal cancer: is hyperinsulinemia the missing link?. Nutr Rev 1998; 56: 275–9
   PubMedGoogle Scholar
• Goodman MT, Cologne JB, Moriwaki H, Vaeth M, Mabuchi K. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med 1997; 26: 144–53
   PubMed Web of Science ®Google Scholar
• Weiderpass E, Gridley G, Persson I, Nyren O, Ekbom A, Adami HO. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 1997; 71: 360–3
   PubMedGoogle Scholar
• Adami HO, Chow WH, Nyren O, Berne C, Linet MS, Ekbom A, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996; 88: 1472–7
   PubMed Web of Science ®Google Scholar
• Braga C, La Vecchia C, Negri E, Franceschi S. Attributable risks for hepatocellular carcinoma in northern Italy. Eur J Cancer 1997; 33: 629–34
   PubMed Web of Science ®Google Scholar
• Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG, Escudero-De Rios P, Salmeron-Castro J, Larrea F, et al. Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control 2000; 11: 707–11
   PubMed Web of Science ®Google Scholar
• Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Bar JA. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000; 11: 185–92
   PubMed Web of Science ®Google Scholar
• Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991; 2: 307–14
   PubMed Web of Science ®Google Scholar
• Lindblad P, Chow WH, Chan J, Bergstrom A, Wolk A, Gridley G, et al. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 1999; 42: 107–12
   PubMed Web of Science ®Google Scholar
• Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Ins 1997; 89: 1360–5
   PubMed Web of Science ®Google Scholar
• Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1990; 39: 40–6
   PubMed Web of Science ®Google Scholar
• Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 2003; 157: 1092–100
   PubMed Web of Science ®Google Scholar
• Colangelo L, Gapstur S, Gann P, Dyer AR, Kiang Liu. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002; 11: 385–91
   PubMed Web of Science ®Google Scholar
• Sandhu MS, Luben R, Khaw KT. Self-reported non-insulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population-based, cross-sectional study. J Epidemiol Community Health 2001; 55: 804–5
   PubMed Web of Science ®Google Scholar
• Kono S, Honjo S, Todoroki I, Nishiwaki M, Hamada H, Nishikawa H, et al. Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan). Cancer Causes Control 1998; 9: 441–6
   PubMedGoogle Scholar
• Nishii T, Kono S, Abe H, Eguchi H, Shimazaki K, Hatano B, et al. Glucose intolerance, plasma insulin levels, and colon adenomas in Japanese men. Jpn J Cancer Res 2001; 92: 836–40
   PubMedGoogle Scholar
• O'Mara BA, Byers T, Schoenfeld E. Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 1985; 38: 435–41
   PubMedGoogle Scholar
• Mc Keown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk?. Cancer Epidemiol Biomarkers Prev 1994; 3: 687–95
   PubMedGoogle Scholar
• Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995; 6: 164–79
   PubMed Web of Science ®Google Scholar
• Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001; 131 Suppl 11: 3109S–20S
   Google Scholar
• Yu H, Rohan T. The role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000; 92: 1472–89
   PubMed Web of Science ®Google Scholar